{"id":"biomatrix-drug-eluting-stent","safety":{"commonSideEffects":[{"rate":null,"effect":"In-stent restenosis"},{"rate":null,"effect":"Stent thrombosis"},{"rate":null,"effect":"Myocardial infarction"},{"rate":null,"effect":"Target lesion revascularization"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The Biomatrix stent is a bare-metal stent platform coated with a bioabsorbable polymer matrix that elutes an anti-proliferative drug (typically a limus-class agent) to inhibit smooth muscle cell proliferation and neointimal hyperplasia. The polymer coating gradually degrades, allowing sustained drug release over several months to reduce the risk of in-stent restenosis while minimizing long-term inflammatory response.","oneSentence":"A drug-eluting stent that releases an active pharmaceutical agent to prevent restenosis (re-narrowing) of coronary arteries after angioplasty.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:40:33.710Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Coronary artery disease requiring percutaneous coronary intervention"},{"name":"Prevention of in-stent restenosis in coronary arteries"}]},"trialDetails":[{"nctId":"NCT02253108","phase":"NA","title":"The OCT SORT-OUT VIII Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Aarhus University Hospital Skejby","startDate":"2014-05","conditions":"Coronary Artery Disease, Angina Pectoris, Myocardial Infarction","enrollment":160},{"nctId":"NCT01186133","phase":"","title":"Evaluation of the First, Second, and New Drug-Eluting Stents in Routine Clinical Practice","status":"RECRUITING","sponsor":"Seung-Jung Park","startDate":"2009-01","conditions":"Coronary Artery Disease, Percutaneous Transluminal Coronary Angioplasty","enrollment":50000},{"nctId":"NCT05799963","phase":"NA","title":"ALPHA LONG Study- BioMatrix AlphaTM Stent Study in Patients With CAD","status":"ACTIVE_NOT_RECRUITING","sponsor":"Biosensors Europe SA","startDate":"2024-02-09","conditions":"Coronary Artery Disease","enrollment":85},{"nctId":"NCT03952273","phase":"NA","title":"Sort Out XI - Combo Stent Versus BioMatrix Alpha Stent","status":"ACTIVE_NOT_RECRUITING","sponsor":"Phillip Freeman","startDate":"2019-08-14","conditions":"Coronary Artery Disease","enrollment":3141},{"nctId":"NCT01065519","phase":"NA","title":"STACCATO: Stent sTrut Apposition and Coverage in Coronary ArTeries: an Optical Coherence Tomography (OCT) Study","status":"COMPLETED","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2009-06","conditions":"Coronary Artery Disease","enrollment":64},{"nctId":"NCT01350778","phase":"","title":"Evaluation of Effectiveness and Safety of BIOMATRIX Stent (IRIS-BIOMATRIX)","status":"COMPLETED","sponsor":"Seung-Jung Park","startDate":"2010-05","conditions":"Coronary Artery Disease","enrollment":837},{"nctId":"NCT03461484","phase":"","title":"e-BioMatrix 6 Month DAPT France","status":"COMPLETED","sponsor":"Biosensors Europe SA","startDate":"2014-03-06","conditions":"Coronary Artery Stenoses, Stable Angina, Ischemia","enrollment":2098},{"nctId":"NCT01060306","phase":"","title":"Optical Coherence Tomography Evaluation of a Biodegradable Polymer-based Drug-eluting Stent","status":"WITHDRAWN","sponsor":"Ospedale Santa Maria Goretti","startDate":"2010-01","conditions":"Coronary Artery Disease","enrollment":""},{"nctId":"NCT02193971","phase":"PHASE4","title":"Harmonizing Optimal Strategy for Treatment of Coronary Artery Diseases Trial - Comparison of REDUCTION of PrasugrEl Dose & POLYmer TECHnology in ACS Patients (HOST REDUCE POLYTECH RCT Trial)","status":"UNKNOWN","sponsor":"Seoul National University Hospital","startDate":"2014-07","conditions":"Acute Coronary Syndrome","enrollment":3384},{"nctId":"NCT02299011","phase":"PHASE4","title":"Comparison of Biomatrix and Orsiro Drug Eluting Stent","status":"COMPLETED","sponsor":"Seoul National University Bundang Hospital","startDate":"2014-07","conditions":"Coronary Artery Disease, Myocardial Ischemia","enrollment":2341},{"nctId":"NCT03026465","phase":"PHASE4","title":"Vessel Injury in Relation With Strut Thickness Assessed by OCT","status":"COMPLETED","sponsor":"Fundacion Investigacion Interhospitalaria Cardiovascular","startDate":"2017-02-16","conditions":"Coronary Artery Disease","enrollment":50},{"nctId":"NCT01397175","phase":"NA","title":"BES, EES, and ZES-R in Real World Practice","status":"TERMINATED","sponsor":"Yonsei University","startDate":"2013-01-16","conditions":"Coronary Artery Disease","enrollment":1960},{"nctId":"NCT01760083","phase":"NA","title":"A Randomized Multicentre Trial to Evaluate the Utilization of Revascularization or Optimal Medical Therapy for the Treatment of Chronic Total Coronary Occlusions","status":"COMPLETED","sponsor":"Euro CTO Club","startDate":"2013-01","conditions":"Chronic Stable Angina, Dyspnea, Coronary Occlusion","enrollment":450},{"nctId":"NCT01915628","phase":"","title":"e-BioMatrix Canada Registry","status":"COMPLETED","sponsor":"Biosensors Europe SA","startDate":"2013-05","conditions":"Device Related MACE and Bleeding","enrollment":535},{"nctId":"NCT00389220","phase":"NA","title":"Limus Eluted From A Durable Versus ERodable Stent Coating","status":"COMPLETED","sponsor":"Biosensors Europe SA","startDate":"2006-11","conditions":"Coronary Disease, Coronary Stenosis","enrollment":1707},{"nctId":"NCT01254487","phase":"","title":"e-BioMatrix PostMarket Surveillance Registry","status":"COMPLETED","sponsor":"Biosensors Europe SA","startDate":"2008-03","conditions":"Coronary Artery Disease","enrollment":1121},{"nctId":"NCT01289002","phase":"","title":"e-BioMatrix PostMarket Registry","status":"COMPLETED","sponsor":"Biosensors Europe SA","startDate":"2008-04","conditions":"Coronary Artery Disease","enrollment":5652},{"nctId":"NCT01856088","phase":"PHASE4","title":"DESTINY TRIAL (Inspiron x Biomatrix)","status":"COMPLETED","sponsor":"Scitech Produtos Medicos SA","startDate":"2013-05","conditions":"Coronary Artery Disease","enrollment":170},{"nctId":"NCT03507205","phase":"","title":"Korean Nationwide Multicenter Pooled Registry of Drug-Eluting Stents","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2008-04-01","conditions":"Coronary Artery Disease","enrollment":17286},{"nctId":"NCT01742507","phase":"PHASE4","title":"A Study Comparing Two Stent on the Degree of Early Stent Healing and Late Lumen Loss.The OCT-ORION Study","status":"COMPLETED","sponsor":"The University of Hong Kong","startDate":"2012-04","conditions":"Coronary Artery Disease","enrollment":60},{"nctId":"NCT01486095","phase":"NA","title":"COmplex BifuRcation Lesions: a Comparison Between the AXXESS Device and Culotte Stenting: an Optical Coherence Tomography (OCT) Study","status":"UNKNOWN","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2011-11-29","conditions":"True Coronary Bifurcation Lesions","enrollment":40},{"nctId":"NCT03089450","phase":"NA","title":"To Evaluate Safety and Efficacy of CGBIO Stent Compared to Biomatrix Flex Stent","status":"UNKNOWN","sponsor":"CGBio Inc.","startDate":"2017-03-22","conditions":"Ischemic Heart Disease, Stable Coronary Artery Disease, Stable Angina","enrollment":112},{"nctId":"NCT03056118","phase":"PHASE4","title":"Optimal Duration of Clopidogrel in Second-Generation Drug-Eluting Stents","status":"COMPLETED","sponsor":"Gangnam Severance Hospital","startDate":"2011-05-02","conditions":"Ischemic Heart Disease","enrollment":1368},{"nctId":"NCT02871622","phase":"","title":"BMX Alpha Registry: a Post-market Registry of the BioMatrix Alpha TM","status":"UNKNOWN","sponsor":"Biosensors Europe SA","startDate":"2016-09","conditions":"Coronary Artery Disease, Stable Angina, Ischemia","enrollment":2000},{"nctId":"NCT02850497","phase":"NA","title":"6-month Intracoronary Optical Coherence Tomography (OCT) Evaluation of Three New Generation Drug Eluting Stent","status":"COMPLETED","sponsor":"Azienda Ospedaliero-Universitaria Careggi","startDate":"2013-08","conditions":"Recurrent Angina After Coronary Stent Placement","enrollment":60},{"nctId":"NCT02084901","phase":"PHASE4","title":"Comparison of Biodegradable Stents: Orsiro and BioMatrix","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2014-03","conditions":"All-comer, Percutaneous Coronary Intervention","enrollment":12},{"nctId":"NCT00962416","phase":"PHASE4","title":"Comparison of Biomatrix Versus Gazelle in ST-Elevation Myocardial Infarction (STEMI)","status":"COMPLETED","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2009-09","conditions":"ST-elevation Myocardial Infarction","enrollment":1161},{"nctId":"NCT02198300","phase":"PHASE4","title":"DES Versus BiOSS LIM - POLBOS II Study","status":"COMPLETED","sponsor":"Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland","startDate":"2012-11","conditions":"Coronary Artery Disease","enrollment":202},{"nctId":"NCT01917201","phase":"NA","title":"Optimal dRug Eluting steNts Implantation Guided By Intravascular Ultrasound and Optical coheRence tomoGraphy ORENBURG","status":"UNKNOWN","sponsor":"The Orenburg Regional Clinical Hospital","startDate":"2012-03","conditions":"Coronary Artery Disease, Coronary Disease, Heart Diseases","enrollment":1000},{"nctId":"NCT01137019","phase":"PHASE3","title":"Optical Coherence Tomography Assessment of Intimal Tissue and Malapposition","status":"UNKNOWN","sponsor":"Dr Peter Barlis","startDate":"2010-10","conditions":"Coronary Heart Disease","enrollment":80},{"nctId":"NCT02192840","phase":"PHASE4","title":"POLish Bifurcation Optimal Stenting Study","status":"COMPLETED","sponsor":"Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland","startDate":"2010-10","conditions":"Coronary Artery Disease","enrollment":243},{"nctId":"NCT02178761","phase":"NA","title":"Imaging and Interventional Study for Erectile Dysfunction and Lower Urinary Tract Symptoms","status":"UNKNOWN","sponsor":"National Taiwan University Hospital","startDate":"2012-10","conditions":"Erectile Dysfunction, Lower Urinary Tract Symptoms, Peripheral Arterial Disease","enrollment":300},{"nctId":"NCT01956448","phase":"NA","title":"SORT-OUT VI - Randomized Clinical Comparison of Biomatrix Flex® and Resolute Integrity®","status":"COMPLETED","sponsor":"Aarhus University Hospital Skejby","startDate":"2011-03","conditions":"Coronary Artery Disease, Angina Pectoris","enrollment":2800},{"nctId":"NCT01534221","phase":"PHASE4","title":"The COOPerative Establishment for Necessary Investigation in Clinical Outcome After Stenting","status":"UNKNOWN","sponsor":"Zealand University Hospital","startDate":"2012-03","conditions":"Ischemic Heart Disease","enrollment":5100},{"nctId":"NCT00888758","phase":"PHASE4","title":"Comparison of Biolimus A9 and Everolimus Drug-Eluting Stents in Patients With ST Segment Elevation Myocardial Infarction","status":"UNKNOWN","sponsor":"Masaryk University","startDate":"2009-05","conditions":"Coronary Heart Disease, Percutaneous Coronary Intervention","enrollment":400}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Biomatrix drug eluting stent (Biosensors,Newport Beach,USA)"],"phase":"marketed","status":"active","brandName":"Biomatrix drug eluting stent","genericName":"Biomatrix drug eluting stent","companyName":"Seoul National University Bundang Hospital","companyId":"seoul-national-university-bundang-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"A drug-eluting stent that releases an active pharmaceutical agent to prevent restenosis (re-narrowing) of coronary arteries after angioplasty. Used for Coronary artery disease requiring percutaneous coronary intervention, Prevention of in-stent restenosis in coronary arteries.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}